C17H20BNO2
281.2 g/mol
Pharmaceutical IntermediateWarning
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine
CAS1009033-87-7EC833-775-6
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a boronic ester derivative featuring a pyridine ring and a dioxaborolane group. It serves as a pharmaceutical intermediate for active pharmaceutical ingredient (API) synthesis, commonly used in medicinal chemistry and drug manufacturing.
Pharmaceutical intermediate for API synthesisBuilding block in drug discovery and development
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1009033-87-7
Related Compounds
SimilarStructure SimilarSimilarity 0.78
4-pyridineboronic acid pinacol ester
CAS181219-01-2
research compound
ReferenceSame Category
(3S,4S)-3-Amino-4-fluoro-1-pyrrolidinecarboxylic acid tert-butyl ester
CAS1009075-43-7
pharmaceutical intermediate
ReferenceSame Category
(3R,4S)-3-Amino-4-fluoro-1-pyrrolidinecarboxylic acid tert-butyl ester
CAS1009075-48-2
pharmaceutical intermediate
ReferenceSame Category
2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride
CAS1009119-83-8
pharmaceutical intermediate
ReferenceSame Category
(S)-2-((1R,3aR,4S,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
CAS100928-03-8
pharmaceutical intermediate
Safety Reference
Warning
H315Causes skin irritation
H319Causes serious eye irritation
Identifiers
IUPAC Name
4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine
InChIKey
PTNMCYWJKRZCDE-UHFFFAOYSA-N
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)C3=CC=NC=C3
Synonyms (8)
—